1.
Santos AP de T, Silva VCM, Mendes-Corrêa MC, et al. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis. Rev. Inst. Med. Trop. São Paulo. 2022;64:e61. doi:10.1590/S1678-9946202264061